Stocktoria
MARIMED INC. MRMD
OTC · OOTC · stock
MARIMED INC. financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $159.8M | $157.7M | $148.6M | $134.0M | $121.5M | $50.9M | $45.6M | $11.9M | $6.1M | $3.6M |
| Gross profit | $57.9M | $62.6M | $65.9M | $64.0M | $66.3M | $31.3M | $18.7M | $7.8M | $3.9M | $1.9M |
| SG&A expense | — | — | — | — | — | — | — | — | — | $770,459 |
| Operating income | -$2.8M | $2.6M | $14.4M | $20.4M | $26.9M | $14.5M | -$41.5M | -$5.4M | $127,650 | $775,304 |
| Interest expense | — | — | $9.2M | $1.7M | $2.4M | $9.8M | $12.7M | $4.4M | $592,417 | -$290,833 |
| Income tax | $3.6M | $8.2M | $9.4M | $5.9M | $16.2M | $2.1M | $67,157 | — | — | — |
| Net income | -$14.5M | -$12.5M | -$16.0M | $13.5M | $7.2M | $2.1M | -$81.2M | -$13.6M | -$1.2M | -$198,852 |
| EPS (diluted) | $-0.04 | $-0.03 | $-0.04 | $0.04 | $0.02 | $0.01 | $-0.39 | — | — | — |
| Operating cash flow | $7.7M | $6.8M | $7.9M | $7.3M | $35.9M | $3.4M | -$24.1M | -$2.9M | $1.8M | -$197,933 |
| Free cash flow | $6.5M | -$5.2M | -$12.2M | -$4.8M | $18.0M | -$1.3M | -$33.8M | -$11.8M | -$19.2M | -$3.6M |
| Cash & equivalents | — | $7.3M | $14.6M | $9.7M | $29.7M | $3.0M | $738,688 | $4.1M | $1.3M | $569,356 |
| Inventory | $36.6M | $33.5M | $25.3M | $19.5M | $9.8M | $6.8M | $1.2M | $90,460 | — | — |
| Total assets | $202.6M | $207.0M | $196.1M | $152.2M | $123.2M | $76.4M | $61.6M | $83.0M | $32.2M | $8.6M |
| Total liabilities | $137.8M | $129.4M | $107.2M | $57.2M | $49.2M | $53.6M | $55.2M | $21.2M | $21.2M | $9.1M |
| Shareholders' equity | $50.0M | $58.5M | $68.9M | $57.3M | $36.3M | $8.1M | $6.3M | $61.8M | $11.0M | -$551,442 |
Growth · year-over-year · Revenue CAGR 52.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +1.3% | +6.1% | +10.9% | +10.3% | +138.7% | +11.6% | +284.8% | +95.3% | +70.2% | +180.6% |
| Net income growth | — | — | -219.0% | +86.4% | +237.0% | — | — | — | — | — |
| EPS growth | — | — | -200.0% | +100.0% | +100.0% | — | — | — | — | — |
| Free cash flow growth | — | — | — | -126.9% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001522767 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.